0 XP   0   0   0

Novo Nordisk A/S Class B










Financial Health of Novo Nordisk A/S Class B




Comparing to competitors in the industry




  Industry Rankings  


Novo Nordisk A/S Class B
Buy, Hold or Sell?

Should you buy, hold or sell Novo Nordisk A/S Class B?

I guess you are interested in Novo Nordisk A/S Class B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Novo Nordisk A/S Class B

Let's start. I'm going to help you getting a better view of Novo Nordisk A/S Class B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Novo Nordisk A/S Class B even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Novo Nordisk A/S Class B is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Novo Nordisk A/S Class B. The closing price on 2022-12-07 was kr890.20 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Novo Nordisk A/S Class B Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Novo Nordisk A/S Class B.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novo Nordisk A/S Class B earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM7.1%-7.1%
TTM7.1%YOY34.3%-27.2%
TTM7.1%5Y20.7%-13.6%
5Y20.7%10Y20.7%0.0%
1.1.2. Return on Assets

Shows how efficient Novo Nordisk A/S Class B is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • 7.4% Return on Assets means that Novo Nordisk A/S Class B generated kr0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novo Nordisk A/S Class B:

  • The MRQ is 7.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.4%TTM6.8%+0.6%
TTM6.8%YOY7.5%-0.7%
TTM6.8%5Y7.1%-0.4%
5Y7.1%10Y7.1%0.0%
1.1.3. Return on Equity

Shows how efficient Novo Nordisk A/S Class B is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • 20.4% Return on Equity means Novo Nordisk A/S Class B generated kr0.20 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novo Nordisk A/S Class B:

  • The MRQ is 20.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.4%TTM18.7%+1.7%
TTM18.7%YOY18.3%+0.4%
TTM18.7%5Y18.5%+0.2%
5Y18.5%10Y18.5%0.0%

1.2. Operating Efficiency of Novo Nordisk A/S Class B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novo Nordisk A/S Class B is operating .

  • Measures how much profit Novo Nordisk A/S Class B makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.3%-9.3%
TTM9.3%YOY21.9%-12.5%
TTM9.3%5Y15.6%-6.3%
5Y15.6%10Y15.6%0.0%
1.2.2. Operating Ratio

Measures how efficient Novo Nordisk A/S Class B is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.041-0.041
TTM0.041YOY0.171-0.130
TTM0.0415Y0.106-0.065
5Y0.10610Y0.1060.000

1.3. Liquidity of Novo Nordisk A/S Class B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novo Nordisk A/S Class B is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.92 means the company has kr0.92 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.917. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.905. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.917TTM0.905+0.012
TTM0.905YOY0.969-0.064
TTM0.9055Y0.937-0.032
5Y0.93710Y0.9370.000
1.3.2. Quick Ratio

Measures if Novo Nordisk A/S Class B is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • A Quick Ratio of 0.41 means the company can pay off kr0.41 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.411. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.503. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.411TTM0.503-0.092
TTM0.503YOY0.699-0.196
TTM0.5035Y0.601-0.098
5Y0.60110Y0.6010.000

1.4. Solvency of Novo Nordisk A/S Class B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novo Nordisk A/S Class B assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novo Nordisk A/S Class B to industry mean.
  • A Debt to Asset Ratio of 0.64 means that Novo Nordisk A/S Class B assets are financed with 63.6% credit (debt) and the remaining percentage (100% - 63.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 0.636. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.636. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.636TTM0.6360.000
TTM0.636YOY0.589+0.048
TTM0.6365Y0.612+0.024
5Y0.61210Y0.6120.000
1.4.2. Debt to Equity Ratio

Measures if Novo Nordisk A/S Class B is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novo Nordisk A/S Class B to the  industry mean.
  • A Debt to Equity ratio of 174.9% means that company has kr1.75 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 1.749. The company is just able to pay all its debts with equity.
  • The TTM is 1.749. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.749TTM1.7490.000
TTM1.749YOY1.438+0.312
TTM1.7495Y1.593+0.156
5Y1.59310Y1.5930.000

2. Market Valuation of Novo Nordisk A/S Class B

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Novo Nordisk A/S Class B generates.

  • Above 15 is considered overpriced but always compare Novo Nordisk A/S Class B to the  industry mean.
  • A PE ratio of 128.08 means the investor is paying kr128.08 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novo Nordisk A/S Class B:

  • The EOD is 149.187. Seems overpriced? -1
  • The MRQ is 128.079. Seems overpriced? -1
  • The TTM is 139.400. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD149.187MRQ128.079+21.108
MRQ128.079TTM139.400-11.321
TTM139.400YOY105.973+33.427
TTM139.4005Y122.686+16.714
5Y122.68610Y122.6860.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Novo Nordisk A/S Class B.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Novo Nordisk A/S Class B:

  • The MRQ is 1,697.310. Seems overpriced? -1
  • The TTM is -320.440. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ1,697.310TTM-320.440+2,017.750
TTM-320.440YOY-125,756.353+125,435.913
TTM-320.4405Y-54,078.688+53,758.248
5Y-54,078.68810Y-54,078.6880.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novo Nordisk A/S Class B is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 26.08 means the investor is paying kr26.08 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Novo Nordisk A/S Class B:

  • The EOD is 30.377. Seems overpriced? -1
  • The MRQ is 26.079. Seems overpriced? -1
  • The TTM is 25.762. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD30.377MRQ26.079+4.298
MRQ26.079TTM25.762+0.316
TTM25.762YOY19.134+6.628
TTM25.7625Y22.448+3.314
5Y22.44810Y22.4480.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novo Nordisk A/S Class B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.480-100%6.846-100%3.663-100%3.663-100%
Book Value Growth--0.8590.8610%0.8600%0.8610%0.8610%
Book Value Per Share--29.30529.3050%26.251+12%27.778+5%27.778+5%
Book Value Per Share Growth---0.016-100%0.011-100%0.014-100%0.014-100%
Current Ratio--0.9170.905+1%0.969-5%0.937-2%0.937-2%
Debt To Asset Ratio--0.6360.6360%0.589+8%0.612+4%0.612+4%
Debt To Equity Ratio--1.7491.7490%1.438+22%1.593+10%1.593+10%
Dividend Per Share--3.9825.241-24%4.312-8%4.776-17%4.776-17%
Dividend Per Share Growth----0.0360%-4497.8300%-1927.6620%-1927.6620%
Eps--5.9675.470+9%4.783+25%5.127+16%5.127+16%
Eps Growth--0.0750.032+133%0.073+3%0.050+51%0.050+51%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.071-100%0.343-100%0.207-100%0.207-100%
Operating Margin---0.093-100%0.219-100%0.156-100%0.156-100%
Operating Ratio---0.041-100%0.171-100%0.106-100%0.106-100%
Pb Ratio30.377+14%26.07925.762+1%19.134+36%22.448+16%22.448+16%
Pe Ratio149.187+14%128.079139.400-8%105.973+21%122.686+4%122.686+4%
Peg Ratio--1697.310-320.440+119%-125756.353+7509%-54078.688+3286%-54078.688+3286%
Price Per Share890.200+14%764.250754.977+1%504.008+52%629.493+21%629.493+21%
Price To Total Gains Ratio223.555+14%191.925147.296+30%122.350+57%134.823+42%134.823+42%
Profit Growth--86.93686.327+1%86.907+0%86.576+0%86.576+0%
Quick Ratio--0.4110.503-18%0.699-41%0.601-32%0.601-32%
Return On Assets--0.0740.068+9%0.075-1%0.071+4%0.071+4%
Return On Equity--0.2040.187+9%0.183+11%0.185+10%0.185+10%
Total Gains Per Share--3.9825.721-30%11.158-64%8.439-53%8.439-53%
Total Gains Per Share Growth----0.0870%-2.8930%-1.2900%-1.2900%
Usd Book Value--9996409800.0009996409800.0000%8954604900.000+12%9475507350.000+5%9475507350.000+5%
Usd Book Value Change Per Share---0.068-100%0.967-100%0.518-100%0.518-100%
Usd Book Value Per Share--4.1414.1410%3.709+12%3.925+5%3.925+5%
Usd Dividend Per Share--0.5630.741-24%0.609-8%0.675-17%0.675-17%
Usd Eps--0.8430.773+9%0.676+25%0.724+16%0.724+16%
Usd Price Per Share125.785+14%107.989106.678+1%71.216+52%88.947+21%88.947+21%
Usd Profit--2035426500.0001866043125.000+9%1631414475.000+25%1748728800.000+16%1748728800.000+16%
Usd Revenue---1354113225.000-100%4754921625.000-100%3054517425.000-100%3054517425.000-100%
Usd Total Gains Per Share--0.5630.808-30%1.577-64%1.192-53%1.192-53%
 EOD+2 -3MRQTTM+12 -15YOY+12 -205Y+13 -1910Y+13 -19

3.2. Fundamental Score

Let's check the fundamental score of Novo Nordisk A/S Class B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15149.187
Price to Book Ratio (EOD)Between0-130.377
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.411
Current Ratio (MRQ)Greater than10.917
Debt to Asset Ratio (MRQ)Less than10.636
Debt to Equity Ratio (MRQ)Less than11.749
Return on Equity (MRQ)Greater than0.150.204
Return on Assets (MRQ)Greater than0.050.074
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Novo Nordisk A/S Class B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose888.050
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in DKK. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets119,482,000
Long-term Assets119,482,000
Total Current Assets
Net Receivables 53,510,000
Inventory 23,222,000
Other Current Assets 5,277,000
Total Current Assets  (as reported)119,482,000
Total Current Assets  (calculated)82,009,000
+/- 37,473,000
Long-term Assets
Property Plant Equipment 63,641,000
Long-term Assets  (as reported)0
Long-term Assets  (calculated)63,641,000
+/- 63,641,000

Liabilities & Shareholders' Equity

Total Current Liabilities130,257,000
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 8,310,000
Other Current Liabilities 120,114,000
Total Current Liabilities  (as reported)130,257,000
Total Current Liabilities  (calculated)128,424,000
+/- 1,833,000
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock456,000
Other Stockholders Equity 2,555,000
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)3,011,000
+/- 3,011,000
Other
Net Tangible Assets 29,756,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
144,922,000
141,387,000
158,095,000
174,084,000
194,508,000
0
0
0
000194,508,000174,084,000158,095,000141,387,000144,922,000
   > Total Current Assets 
65,809,000
61,389,000
77,146,000
91,213,000
85,595,000
86,537,000
102,979,000
119,482,000
119,482,000102,979,00086,537,00085,595,00091,213,00077,146,00061,389,00065,809,000
       Short-term Investments 
0
1,983,000
2,987,000
5,897,000
6,765,000
0
0
0
0006,765,0005,897,0002,987,0001,983,0000
       Net Receivables 
27,734,000
28,029,000
30,223,000
35,452,000
46,799,000
44,166,000
46,639,000
53,510,000
53,510,00046,639,00044,166,00046,799,00035,452,00030,223,00028,029,00027,734,000
       Inventory 
18,536,000
18,653,000
18,822,000
18,899,000
19,621,000
20,289,000
21,706,000
23,222,000
23,222,00021,706,00020,289,00019,621,00018,899,00018,822,00018,653,00018,536,000
       Other Current Assets 
2,332,000
1,153,000
885,000
1,472,000
1,690,000
1,936,000
3,597,000
5,277,000
5,277,0003,597,0001,936,0001,690,0001,472,000885,0001,153,0002,332,000
   > Long-term Assets 00000000
       Property Plant Equipment 
50,269,000
51,429,000
52,076,000
52,863,000
55,362,000
56,399,000
59,556,000
63,641,000
63,641,00059,556,00056,399,00055,362,00052,863,00052,076,00051,429,00050,269,000
       Intangible Assets 
20,657,000
20,357,000
20,272,000
20,526,000
43,171,000
0
0
0
00043,171,00020,526,00020,272,00020,357,00020,657,000
> Total Liabilities 
81,597,000
82,891,000
92,536,000
107,972,000
123,762,000
0
0
0
000123,762,000107,972,00092,536,00082,891,00081,597,000
   > Total Current Liabilities 
70,273,000
72,384,000
72,798,000
88,328,000
99,516,000
95,602,000
109,655,000
130,257,000
130,257,000109,655,00095,602,00099,516,00088,328,00072,798,00072,384,00070,273,000
       Short-term Debt 
6,684,000
0
0
0
0
0
0
0
00000006,684,000
       Accounts payable 
0
0
7,616,000
8,877,000
8,870,000
6,679,000
14,654,000
8,310,000
8,310,00014,654,0006,679,0008,870,0008,877,0007,616,00000
       Other Current Liabilities 
0
0
63,881,000
78,101,000
26,395,000
87,527,000
93,745,000
120,114,000
120,114,00093,745,00087,527,00026,395,00078,101,00063,881,00000
   > Long-term Liabilities 00000000
       Other Liabilities 
0
0
7,275,000
7,246,000
11,285,000
10,900,000
10,643,000
11,763,000
11,763,00010,643,00010,900,00011,285,0007,246,0007,275,00000
> Total Stockholder Equity
63,325,000
58,496,000
65,559,000
66,112,000
70,746,000
0
0
0
00070,746,00066,112,00065,559,00058,496,00063,325,000
   Common Stock
470,000
470,000
462,000
462,000
462,000
462,000
456,000
456,000
456,000456,000462,000462,000462,000462,000470,000470,000
   Retained Earnings 
63,589,000
58,035,000
67,179,000
67,914,000
72,004,000
66,612,000
73,166,000
73,673,000
73,673,00073,166,00066,612,00072,004,00067,914,00067,179,00058,035,00063,589,000
   Capital Surplus 00000000
   Treasury Stock000-6,000-4,000-3,000-9,000-8,000
   Other Stockholders Equity 
-726,000
0
-2,079,000
-2,260,000
-1,714,000
-517,000
833,000
2,555,000
2,555,000833,000-517,000-1,714,000-2,260,000-2,079,0000-726,000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue140,800,000
Cost of Revenue-23,658,000
Gross Profit117,142,000117,142,000
 
Operating Income (+$)
Gross Profit117,142,000
Operating Expense--
Operating Income58,644,000117,142,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative40,409,000
Selling And Marketing Expenses-
Operating Expense-40,409,000
 
Net Interest Income (+$)
Interest Income558,000
Interest Expense-0
Net Interest Income-558,000
 
Pretax Income (+$)
Operating Income58,644,000
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)59,080,00058,644,000
EBIT - interestExpense = 59,341,000
59,080,000
47,757,000
Interest Expense0
Earnings Before Interest and Taxes (ebit)59,341,00059,080,000
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax59,080,000
Tax Provision-11,323,000
Net Income From Continuing Ops-47,757,000
Net Income47,757,000
Net Income Applicable To Common Shares47,757,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses456,000
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
EMGA.LSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EMGA.LSE.

EMGA.LSE Daily Candlestick Chart
EMES.LSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EMES.LSE.

EMES.LSE Daily Candlestick Chart
EMDD.LSE
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EMDD.LSE.

EMDD.LSE Daily Candlestick Chart
EMIG.LSE
2 minutes ago

I found you a Death Cross on the daily chart of EMIG.LSE.

EMIG.LSE Daily Candlestick Chart
ELBM.NASDAQ
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ELBM.NASDAQ.

ELBM.NASDAQ Daily Candlestick Chart
DS2P.LSE
15 minutes ago

I found you a Death Cross on the daily chart of DS2P.LSE.

DS2P.LSE Daily Candlestick Chart
DQD.TO
16 minutes ago

I found you a Golden Cross on the daily chart of DQD.TO.

DQD.TO Daily Candlestick Chart
DNGDF.PINK
19 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DNGDF.PINK.

DNGDF.PINK Daily Candlestick Chart
CU2G.LSE
27 minutes ago

I found you a Death Cross on the daily chart of CU2G.LSE.

CU2G.LSE Daily Candlestick Chart
CONTAINE.BSE
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CONTAINE.BSE.

CONTAINE.BSE Daily Candlestick Chart
CNXMEDIA.INDX
30 minutes ago

I found you a Golden Cross on the daily chart of CNXMEDIA.INDX.

CNXMEDIA.INDX Daily Candlestick Chart
CNCT.PINK
32 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNCT.PINK.

CNCT.PINK Daily Candlestick Chart
CNA.LSE
32 minutes ago

I found you a Golden Cross on the daily chart of CNA.LSE.

CNA.LSE Daily Candlestick Chart
CGUSY.PINK
37 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CGUSY.PINK.

CGUSY.PINK Daily Candlestick Chart
CENQ.NASDAQ
38 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENQ.NASDAQ.

CENQ.NASDAQ Daily Candlestick Chart
CAVR.PINK
40 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CAVR.PINK.

CAVR.PINK Daily Candlestick Chart
CAR.LSE
40 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CAR.LSE.

CAR.LSE Daily Candlestick Chart
BVIC.LSE
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BVIC.LSE.

BVIC.LSE Daily Candlestick Chart
BRGC.PINK
47 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BRGC.PINK.

BRGC.PINK Daily Candlestick Chart
BLBLIMITED.BSE
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BLBLIMITED.BSE.

BLBLIMITED.BSE Daily Candlestick Chart
BIOR.NASDAQ
51 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BIOR.NASDAQ.

BIOR.NASDAQ Daily Candlestick Chart
BHL.LSE
52 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BHL.LSE.

BHL.LSE Daily Candlestick Chart
AAATECH.NSE
54 minutes ago

I found you a Death Cross on the daily chart of AAATECH.NSE.

AAATECH.NSE Daily Candlestick Chart
BBEG.MI
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BBEG.MI.

BBEG.MI Daily Candlestick Chart